The North Thames Genomic Medicine Centre’s (GMC) has recruited 5,200 genomes to the 100,000 Genomes project for rare diseases, making up around 28% of those recruited nationally.
In a new editorial published in Human Gene Therapy, leading researchers call for urgent action to ensure continued access to critical funding and ongoing collaborative opportunities with the broader scientific community in the European Union.
Research led by BRC-funded Professor Lucy Wedderburn has shown that muscle pathology and myositis-specific antibodies (MSA) predict the risk of remaining on treatment in Juvenile Dermatomyositis (JDM). These findings could aid risk stratification.
The UK National Screening Committee, based on a research programme led by BRC-funded Professor Lynn Chitty, has recommended to the Government that NIPT for Down’s Syndrome be implemented into the NHS maternity care pathway and is currently awaiting minist
The Zayed Centre for Research into Rare Disease in Children (ZCR) is currently under construction in Guildford Street. Importantly this will include a dedicated facility comprising seven ‘cleanrooms’ where gene and cell therapy medicinal products can be m